Trial intelligence / Profile preview

Esomeprazole in Functional Dyspepsia

NCT01349413Phase 4Completed

Sponsor
The Chinese University of Hong Kong
Start
Aug 2011
Primary completion
Dec 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in functional dyspepsia (FD) comparing Esomeprazole with Placebo (2 arms). Primary endpoint: Proportion of patients who report positive response to adequate relief of dyspeptic symptoms at 8 weeks. Started Aug 2011; status: completed.

02

Drugs

esomeprazole
03

Conditions

functional dyspepsia (FD)

Beyond the preview

Go deeper on NCT01349413.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01349413.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call